Orsi Fabienne auteur aut IRD Singh S. auteur aut IRD Sagaon Teyssier Luis auteur aut IRD text journalArticle eng text/pdf born digital access Since the early 2000s, the question of access to medicines at affordable prices for Southern populations has appeared as one of the major challenges for the international governance of health. But what is at stake is the creation of market for medicines in the global South, particularly countries in the Sub-Saharan Africa. These markets are new in nature in the sense that they are driven by international organisations where Southern firms, especially from India, occupy an increasingly important position. However, the specificity of these markets and the way they are constituted have been little analysed. In this article, we suggest focusing the attention on the constitution of the market of antimalarial drugs and highlighting the role played by Southern firms in this market. Our study focuses on the public sector market of antimalarial drugs. We provide an institutional and quantitative analysis of the creation of this public market. We then discuss the growing importance of the Southern firms, mainly Indian and Chinese, in this market. specialized AFRIQUE SUBSAHARIENNE CHINE INDE MONDE 056 096 23 3 349-370 2018 0971-7218 https://www.documentation.ird.fr/hor/fdi:010073781 10.1177/0971721818762906 0971-7218 [F B010073781] https://www.documentation.ird.fr/hor/fdi:010073781 https://www.documentation.ird.fr/intranet/publi/2018/09/010073781.pdf Accès réservé (Intranet de l'IRD) IRD - Base Horizon / Pleins textes 2018-10-03 2024-09-02 fdi:010073781 fre